The epidemiology of Kawasaki disease in an urban hospital: Does African American race protect against coronary artery aneurysms?

Pediatric Cardiology

Volumn 26, Issue 6, 2005, Pages 775-781

  Porcalla, A R ^a,b   Sable, C A ^a   Patel, K M ^a   Martin, G R ^a   Singh, N ^a,c  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b University Hospitals and Clinics Holmes County   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

African American ethnicity; Coronary arteries; Epidemiology; Kawasaki disease

Indexed keywords

ADOLESCENT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CHILD; CORONARY ARTERY ANEURYSM; DISEASE DURATION; ELECTROCARDIOGRAM; ETHNOLOGY; EVALUATION; FEMALE; FEVER; HEALTH SERVICE; HISPANIC; HOSPITAL ADMISSION; HUMAN; IMMUNITY; INCOME; INFANT; KRUSKAL WALLIS TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; PROTECTION; RACE; RISK FACTOR; STATISTICAL ANALYSIS;

ADOLESCENT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; CHILD; CHILD, PRESCHOOL; CORONARY ANEURYSM; FEMALE; HOSPITALS, URBAN; HUMANS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; SEASONS; SEX FACTORS; UNITED STATES;

EID: 31144478123     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-005-0916-5     Document Type: Article

References (36)

1. Anderson MS, Burns J, Treadwell TA, Pietra BA, Glode MP (2001) Erythrocyte sedimentation rate and C-reactive protein discrepancy and high prevalence of coronary artery abnormalities in Kawasaki disease. Pediatr Infect Dis J 20:698-702
2. Belay ED, Holman RC, Clarke MJ, et al. (2000) The incidence of Kawasaki syndrome in West Coast health maintenance organizations. Pediatr Infect Dis J 19:828-832
3. Bonacini M, Groshen MD, Yu MC, Govindarajan S, Lindsay KL (2001) Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County. Am J Gastroenterol 96:2438-2441
4. Brogger J, Eagan T, Eide GE, Bakke P, Gulsvik A (2004) Bias in retrospective studies of trends in asthma incidence. Eur Respir J 23:281-286
5. Bronstein DE, Dille AN, Austin JP, et al. (2000) Relationship of climate, ethnicity and socioeconomic status to Kawasaki disease in San Diego County, 1994 through 1998. Pediatr Infect Dis J 19:1087-1091
6. Burns JC, Kushner HI, Bastian JF, et al. (2000) Kawasaki disease: a brief history. Pediatrics 106:E27
7. Curtis N, Zheng R, Lamb JR, Levin M (1995) Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Child 72:308-311
8. Fernandes Filho JA, Vedeler CA, Myhr KM, Nyland H, Pandey JP (2002) TNF-alpha and -beta gene polymorphisms in multiple sclerosis: a highly significant role for determinants in the first intron of the TNF-beta gene. Autoimmunity 35:377-380
9. Fleckenstein J (2004) Chronic hepatitis C in African Americans and other minority groups. Curr Gastroenterol Rep 6:66-70
10. Fukunishi M, Kikkawa M, Hamana K, et al. (2000) Prediction of nonresponsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset. J Pediatr 137:172-176
11. Gupta M, Noel GJ, Schaefer M, et al. (2001) Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment. J Clin Immunol 21:193-199
12. Han RK, Sinclair B, Newman A, et al. (2000) Recognition and management of Kawasaki disease. Cmaj 162:807-812
13. Holman RC, Curns AT, Belay ED, Steiner CA, Schonberger LB (2003) Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 112:495-501
14. Honkanen VE, McCrindle BW, Laxer RM, et al. (2003) Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr Cordial 24:122-126
15. Jiao F, Yang L, Li Y, et al. (2001) Epidemiologic and clinical characteristics of Kawasaki disease in Shaanxi Province. China, 1993-1997. J Trop Pediatr 47:54-56
16. Krieger N, Chen JT, Selby JV (1999) Comparing individual-based and household-based measures of social class to assess class inequalities in women's health: a methodological study of 684 US women. J Epidemiol Community Health 53:612-623
17. Krieger N, Williams DR, Moss NE (1997) Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health 18:341-378
18. Laupland KB, Dele Davies H (1999) Epidemiology, etiology, and management of Kawasaki disease: state of the art. Pediatr Cardiol 20:177-183
19. Lazarus R, Klimecki WT, Palmer LJ, et al. (2002) Single-nucleotide polymorphisms in the interleukin-10 gene: differences in frequencies, linkage disequilibrium patterns, and haplotypes in three United States ethnic groups. Genomics 80:223-228
20. Leung DY, Meissner HC, Fulton DR, Quimby F, Schlievert PM (1995) Superantigens in Kawasaki syndrome. Clin Immunol Immunopathol 77:119-126
21. Meissner HC, Leung DY (2003) Kawasaki syndrome: where are the answers? Pediatrics 112:672-676
22. Nakamura Y, Yashiro M, Uehara R, et al. (2003) Case-control study of giant coronary aneurysms due to Kawasaki disease. Pediatr Int 45:410-413
23. Nakamura Y, Yashiro M, Uehara R, et al. (2004) Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr Int 46:33-38
24. Newburger JW, Takahashi M, Burns JC, et al. (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341-347
25. Nomura Y, Yoshinaga M, Masuda K, Takei S, Miyata K (2002) Maternal antibody against toxic shock syndrome toxin-1 may protect infants younger than 6 months of age from developing Kawasaki syndrome. J Infect Dis 185:1677-1680
26. Pandey JP, Frederick M (2002) TNF-alpha, IL1-beta, and immunoglobulin (GM and KM) gene polymorphisms in sarcoidosis. Hum Immunol 63:485-491
27. Rauch AM, Glode MP, Wiggins JWJr, et al. (1991) Outbreak of Kawasaki syndrome in Denver, Colorado: association with rug and carpet cleaning. Pediatrics 87:663-669
28. Shulman ST, McAuley JB, Pachman LM, Miller ML, Ruschhaupt DG (1987) Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population. Am J Pis Child. 141:420-425
29. Shulman ST, Melish M, Inoue O, Kato H, Tomita S (1993) Immunoglobulin allotypic markers in Kawasaki disease. J Pediatr 122:84-86
30. Sohn MH, Noh SY, Chang W, Shin KM, Kim DS (2003) Circulating interleukin 17 is increased in the acute stage of Kawasaki disease,. Scand J Rheumatol 32:364-366
31. Stockheim JA, Innocentini N, Shulman ST (2000) Kawasaki disease in older children and adolescents. J Pediatr 137:250-252
32. Sugimoto K, Stadanlick J, Ikeda F, et al. (2003) Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response. Hepatology 37:590-599
33. Treadwell TA, Maddox RA, Holman RC, et al. (2002) Investigation of Kawasaki syndrome risk factors in Colorado. Pediatr Infect Dis J 21:976-978
34. Tzen KT, Wu MH, Wang JK, et al. (1997) Prognosis of coronary arterial lesions in Kawasaki disease treated without intravenous immunoglobulin. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 38:32-37
35. Yanagawa H, Nakamura Y, Yashiro M, et al. (2001) Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 107:E33
36. Yoshioka T, Matsutani T, Toyosaki-Maeda T, et al. (2003) Relation of streptococcal pyrogenic exotoxin C as a causative superantigen for Kawasaki disease. Pediatr Res 53: 403-410